Incremental innovation consists of introducing in Brazilian market existing assets in the world or promoting incremental improves, such as new associations, formulations, therapeutic indications, and application of different technologies in existing assets, thus bringing innovative proposals to understand the needs of doctors and patients.

Perspectives for the pharmaceutical industry point out to incremental innovation and nanotechnology as promising areas for the next years. Foreseeing this trend, In November 2017, Aché inaugurated the Nanotechnology Innovation Laboratory Enterprise (NILE) inside the Guarulhos Plant, in partnership with Ferring Pharmaceuticals. A unique model in Brazil focused on the research and development of new technological platforms based on Nanotechnology, which can be applied in drugs, cosmetics and nutritional products.